nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—SLC22A1—obesity	0.0791	0.187	CbGaD
Pramipexole—DRD4—obesity	0.0763	0.18	CbGaD
Pramipexole—HTR1B—obesity	0.0678	0.16	CbGaD
Pramipexole—DRD1—obesity	0.0646	0.152	CbGaD
Pramipexole—DRD1—Phenylpropanolamine—obesity	0.0564	0.178	CbGbCtD
Pramipexole—HTR2C—obesity	0.0553	0.13	CbGaD
Pramipexole—ADRA2C—Methamphetamine—obesity	0.0472	0.149	CbGbCtD
Pramipexole—DRD2—obesity	0.0456	0.107	CbGaD
Pramipexole—ADRA2B—Methamphetamine—obesity	0.0448	0.142	CbGbCtD
Pramipexole—ADRA2A—Benzphetamine—obesity	0.039	0.123	CbGbCtD
Pramipexole—ADRA2A—Phenylpropanolamine—obesity	0.0372	0.118	CbGbCtD
Pramipexole—HTR2A—obesity	0.0352	0.0831	CbGaD
Pramipexole—SLC22A2—Cimetidine—obesity	0.0323	0.102	CbGbCtD
Pramipexole—ADRA2A—Methamphetamine—obesity	0.0312	0.0986	CbGbCtD
Pramipexole—SLC22A1—Cimetidine—obesity	0.028	0.0887	CbGbCtD
Pramipexole—HTR2A—sympathetic nervous system—obesity	0.00103	0.0961	CbGeAlD
Pramipexole—HTR2A—vagus nerve—obesity	0.000996	0.0931	CbGeAlD
Pramipexole—HTR2A—autonomic nervous system—obesity	0.000691	0.0646	CbGeAlD
Pramipexole—HTR1A—hindbrain—obesity	0.000489	0.0457	CbGeAlD
Pramipexole—DRD2—hindbrain—obesity	0.000441	0.0413	CbGeAlD
Pramipexole—SLC22A2—digestive system—obesity	0.000325	0.0304	CbGeAlD
Pramipexole—DRD5—endocrine gland—obesity	0.000314	0.0293	CbGeAlD
Pramipexole—HTR2A—hindbrain—obesity	0.000291	0.0272	CbGeAlD
Pramipexole—HTR1B—cardiovascular system—obesity	0.000283	0.0265	CbGeAlD
Pramipexole—HTR2B—adrenal cortex—obesity	0.000279	0.0261	CbGeAlD
Pramipexole—HTR1D—cardiovascular system—obesity	0.000274	0.0256	CbGeAlD
Pramipexole—DRD2—respiratory system—obesity	0.00027	0.0252	CbGeAlD
Pramipexole—HTR2B—cardiovascular system—obesity	0.000255	0.0238	CbGeAlD
Pramipexole—SLC22A1—adipose tissue—obesity	0.000244	0.0228	CbGeAlD
Pramipexole—HTR1A—cardiovascular system—obesity	0.000229	0.0214	CbGeAlD
Pramipexole—HTR2B—adipose tissue—obesity	0.000225	0.021	CbGeAlD
Pramipexole—ADRA2A—islet of Langerhans—obesity	0.000221	0.0207	CbGeAlD
Pramipexole—ADRA2C—adrenal cortex—obesity	0.00022	0.0206	CbGeAlD
Pramipexole—HTR2B—digestive system—obesity	0.000212	0.0198	CbGeAlD
Pramipexole—HTR2B—adrenal gland—obesity	0.000202	0.0189	CbGeAlD
Pramipexole—HTR1B—endocrine gland—obesity	0.000194	0.0182	CbGeAlD
Pramipexole—SLC22A1—endocrine gland—obesity	0.00019	0.0177	CbGeAlD
Pramipexole—DRD2—pituitary gland—obesity	0.000183	0.0171	CbGeAlD
Pramipexole—HTR1A—adrenal gland—obesity	0.000181	0.0169	CbGeAlD
Pramipexole—HTR2A—respiratory system—obesity	0.000178	0.0166	CbGeAlD
Pramipexole—ADRA2C—pituitary gland—obesity	0.000178	0.0166	CbGeAlD
Pramipexole—ADRA2C—adipose tissue—obesity	0.000177	0.0165	CbGeAlD
Pramipexole—SLC22A1—liver—obesity	0.000171	0.016	CbGeAlD
Pramipexole—ADRA2C—adrenal gland—obesity	0.000159	0.0148	CbGeAlD
Pramipexole—HTR1A—endocrine gland—obesity	0.000157	0.0147	CbGeAlD
Pramipexole—ADRA2A—pituitary gland—obesity	0.000142	0.0133	CbGeAlD
Pramipexole—DRD2—endocrine gland—obesity	0.000142	0.0132	CbGeAlD
Pramipexole—ADRA2A—adipose tissue—obesity	0.000141	0.0132	CbGeAlD
Pramipexole—HTR2A—cardiovascular system—obesity	0.000136	0.0127	CbGeAlD
Pramipexole—ADRA2A—adrenal gland—obesity	0.000127	0.0118	CbGeAlD
Pramipexole—ADRA2C—liver—obesity	0.000124	0.0116	CbGeAlD
Pramipexole—HTR2A—pituitary gland—obesity	0.000121	0.0113	CbGeAlD
Pramipexole—HTR2A—digestive system—obesity	0.000113	0.0106	CbGeAlD
Pramipexole—ADRA2A—endocrine gland—obesity	0.00011	0.0103	CbGeAlD
Pramipexole—HTR2A—adrenal gland—obesity	0.000108	0.0101	CbGeAlD
Pramipexole—HTR2A—endocrine gland—obesity	9.34e-05	0.00873	CbGeAlD
Pramipexole—HTR2A—liver—obesity	8.42e-05	0.00787	CbGeAlD
Pramipexole—Dysgeusia—Bupropion—obesity	4.63e-05	0.000316	CcSEcCtD
Pramipexole—Chest pain—Sibutramine—obesity	4.62e-05	0.000315	CcSEcCtD
Pramipexole—Arthralgia—Sibutramine—obesity	4.62e-05	0.000315	CcSEcCtD
Pramipexole—Myalgia—Sibutramine—obesity	4.62e-05	0.000315	CcSEcCtD
Pramipexole—Anxiety—Sibutramine—obesity	4.6e-05	0.000314	CcSEcCtD
Pramipexole—Nervousness—Bupropion—obesity	4.59e-05	0.000313	CcSEcCtD
Pramipexole—Oedema—Orlistat—obesity	4.57e-05	0.000312	CcSEcCtD
Pramipexole—Back pain—Bupropion—obesity	4.57e-05	0.000312	CcSEcCtD
Pramipexole—Abdominal pain upper—Topiramate—obesity	4.57e-05	0.000311	CcSEcCtD
Pramipexole—Orthostatic hypotension—Topiramate—obesity	4.57e-05	0.000311	CcSEcCtD
Pramipexole—Discomfort—Sibutramine—obesity	4.56e-05	0.000311	CcSEcCtD
Pramipexole—Hypokalaemia—Topiramate—obesity	4.55e-05	0.00031	CcSEcCtD
Pramipexole—Muscle spasms—Bupropion—obesity	4.54e-05	0.00031	CcSEcCtD
Pramipexole—Infection—Orlistat—obesity	4.54e-05	0.00031	CcSEcCtD
Pramipexole—Breast disorder—Topiramate—obesity	4.52e-05	0.000308	CcSEcCtD
Pramipexole—Dry mouth—Sibutramine—obesity	4.51e-05	0.000308	CcSEcCtD
Pramipexole—Nervous system disorder—Orlistat—obesity	4.48e-05	0.000306	CcSEcCtD
Pramipexole—Nasopharyngitis—Topiramate—obesity	4.47e-05	0.000305	CcSEcCtD
Pramipexole—Confusional state—Sibutramine—obesity	4.46e-05	0.000304	CcSEcCtD
Pramipexole—Vision blurred—Bupropion—obesity	4.45e-05	0.000304	CcSEcCtD
Pramipexole—Skin disorder—Orlistat—obesity	4.44e-05	0.000303	CcSEcCtD
Pramipexole—Tremor—Bupropion—obesity	4.43e-05	0.000302	CcSEcCtD
Pramipexole—Gastritis—Topiramate—obesity	4.43e-05	0.000302	CcSEcCtD
Pramipexole—Oedema—Sibutramine—obesity	4.42e-05	0.000302	CcSEcCtD
Pramipexole—Hyperhidrosis—Orlistat—obesity	4.42e-05	0.000301	CcSEcCtD
Pramipexole—Muscular weakness—Topiramate—obesity	4.41e-05	0.000301	CcSEcCtD
Pramipexole—Infection—Sibutramine—obesity	4.4e-05	0.0003	CcSEcCtD
Pramipexole—Ill-defined disorder—Bupropion—obesity	4.39e-05	0.000299	CcSEcCtD
Pramipexole—Anaemia—Bupropion—obesity	4.37e-05	0.000298	CcSEcCtD
Pramipexole—Shock—Sibutramine—obesity	4.35e-05	0.000297	CcSEcCtD
Pramipexole—Abdominal distension—Topiramate—obesity	4.35e-05	0.000297	CcSEcCtD
Pramipexole—Agitation—Bupropion—obesity	4.34e-05	0.000296	CcSEcCtD
Pramipexole—Thrombocytopenia—Sibutramine—obesity	4.33e-05	0.000295	CcSEcCtD
Pramipexole—Asthma—Topiramate—obesity	4.32e-05	0.000295	CcSEcCtD
Pramipexole—Dysphagia—Topiramate—obesity	4.32e-05	0.000295	CcSEcCtD
Pramipexole—Tachycardia—Sibutramine—obesity	4.32e-05	0.000294	CcSEcCtD
Pramipexole—Skin disorder—Sibutramine—obesity	4.3e-05	0.000293	CcSEcCtD
Pramipexole—Hyperhidrosis—Sibutramine—obesity	4.28e-05	0.000292	CcSEcCtD
Pramipexole—Malaise—Bupropion—obesity	4.26e-05	0.000291	CcSEcCtD
Pramipexole—Vertigo—Bupropion—obesity	4.25e-05	0.00029	CcSEcCtD
Pramipexole—Syncope—Bupropion—obesity	4.24e-05	0.000289	CcSEcCtD
Pramipexole—Pancreatitis—Topiramate—obesity	4.24e-05	0.000289	CcSEcCtD
Pramipexole—Leukopenia—Bupropion—obesity	4.23e-05	0.000288	CcSEcCtD
Pramipexole—Anorexia—Sibutramine—obesity	4.22e-05	0.000288	CcSEcCtD
Pramipexole—Angina pectoris—Topiramate—obesity	4.21e-05	0.000287	CcSEcCtD
Pramipexole—Palpitations—Bupropion—obesity	4.18e-05	0.000285	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Orlistat—obesity	4.17e-05	0.000284	CcSEcCtD
Pramipexole—Bronchitis—Topiramate—obesity	4.16e-05	0.000283	CcSEcCtD
Pramipexole—Loss of consciousness—Bupropion—obesity	4.15e-05	0.000283	CcSEcCtD
Pramipexole—Abdominal discomfort—Topiramate—obesity	4.14e-05	0.000282	CcSEcCtD
Pramipexole—Insomnia—Orlistat—obesity	4.14e-05	0.000282	CcSEcCtD
Pramipexole—Hypotension—Sibutramine—obesity	4.13e-05	0.000282	CcSEcCtD
Pramipexole—Cough—Bupropion—obesity	4.12e-05	0.000281	CcSEcCtD
Pramipexole—Paraesthesia—Orlistat—obesity	4.11e-05	0.00028	CcSEcCtD
Pramipexole—Convulsion—Bupropion—obesity	4.1e-05	0.000279	CcSEcCtD
Pramipexole—Hypertension—Bupropion—obesity	4.08e-05	0.000278	CcSEcCtD
Pramipexole—Dysuria—Topiramate—obesity	4.04e-05	0.000276	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Sibutramine—obesity	4.03e-05	0.000275	CcSEcCtD
Pramipexole—Dyspepsia—Orlistat—obesity	4.02e-05	0.000274	CcSEcCtD
Pramipexole—Myalgia—Bupropion—obesity	4.02e-05	0.000274	CcSEcCtD
Pramipexole—Arthralgia—Bupropion—obesity	4.02e-05	0.000274	CcSEcCtD
Pramipexole—Chest pain—Bupropion—obesity	4.02e-05	0.000274	CcSEcCtD
Pramipexole—Upper respiratory tract infection—Topiramate—obesity	4.02e-05	0.000274	CcSEcCtD
Pramipexole—Anxiety—Bupropion—obesity	4.01e-05	0.000273	CcSEcCtD
Pramipexole—Insomnia—Sibutramine—obesity	4e-05	0.000273	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	4e-05	0.000272	CcSEcCtD
Pramipexole—Pollakiuria—Topiramate—obesity	3.99e-05	0.000272	CcSEcCtD
Pramipexole—Erectile dysfunction—Topiramate—obesity	3.98e-05	0.000271	CcSEcCtD
Pramipexole—Discomfort—Bupropion—obesity	3.98e-05	0.000271	CcSEcCtD
Pramipexole—Decreased appetite—Orlistat—obesity	3.97e-05	0.000271	CcSEcCtD
Pramipexole—Paraesthesia—Sibutramine—obesity	3.97e-05	0.000271	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Orlistat—obesity	3.95e-05	0.000269	CcSEcCtD
Pramipexole—Dyspnoea—Sibutramine—obesity	3.95e-05	0.000269	CcSEcCtD
Pramipexole—Photosensitivity reaction—Topiramate—obesity	3.94e-05	0.000269	CcSEcCtD
Pramipexole—Fatigue—Orlistat—obesity	3.94e-05	0.000269	CcSEcCtD
Pramipexole—Dry mouth—Bupropion—obesity	3.94e-05	0.000268	CcSEcCtD
Pramipexole—Somnolence—Sibutramine—obesity	3.93e-05	0.000268	CcSEcCtD
Pramipexole—Weight increased—Topiramate—obesity	3.93e-05	0.000268	CcSEcCtD
Pramipexole—Weight decreased—Topiramate—obesity	3.91e-05	0.000267	CcSEcCtD
Pramipexole—Pain—Orlistat—obesity	3.91e-05	0.000267	CcSEcCtD
Pramipexole—Hyperglycaemia—Topiramate—obesity	3.9e-05	0.000266	CcSEcCtD
Pramipexole—Dyspepsia—Sibutramine—obesity	3.9e-05	0.000266	CcSEcCtD
Pramipexole—Confusional state—Bupropion—obesity	3.89e-05	0.000265	CcSEcCtD
Pramipexole—Pneumonia—Topiramate—obesity	3.88e-05	0.000264	CcSEcCtD
Pramipexole—Oedema—Bupropion—obesity	3.86e-05	0.000263	CcSEcCtD
Pramipexole—Infestation NOS—Topiramate—obesity	3.85e-05	0.000263	CcSEcCtD
Pramipexole—Infestation—Topiramate—obesity	3.85e-05	0.000263	CcSEcCtD
Pramipexole—Decreased appetite—Sibutramine—obesity	3.85e-05	0.000262	CcSEcCtD
Pramipexole—Depression—Topiramate—obesity	3.84e-05	0.000262	CcSEcCtD
Pramipexole—Infection—Bupropion—obesity	3.83e-05	0.000261	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Sibutramine—obesity	3.82e-05	0.00026	CcSEcCtD
Pramipexole—Shock—Bupropion—obesity	3.8e-05	0.000259	CcSEcCtD
Pramipexole—Renal failure—Topiramate—obesity	3.79e-05	0.000258	CcSEcCtD
Pramipexole—Constipation—Sibutramine—obesity	3.78e-05	0.000258	CcSEcCtD
Pramipexole—Pain—Sibutramine—obesity	3.78e-05	0.000258	CcSEcCtD
Pramipexole—Nervous system disorder—Bupropion—obesity	3.78e-05	0.000258	CcSEcCtD
Pramipexole—Neuropathy peripheral—Topiramate—obesity	3.78e-05	0.000258	CcSEcCtD
Pramipexole—Thrombocytopenia—Bupropion—obesity	3.78e-05	0.000258	CcSEcCtD
Pramipexole—Feeling abnormal—Orlistat—obesity	3.77e-05	0.000257	CcSEcCtD
Pramipexole—Tachycardia—Bupropion—obesity	3.76e-05	0.000257	CcSEcCtD
Pramipexole—Skin disorder—Bupropion—obesity	3.75e-05	0.000255	CcSEcCtD
Pramipexole—Conjunctivitis—Topiramate—obesity	3.75e-05	0.000255	CcSEcCtD
Pramipexole—Urinary tract infection—Topiramate—obesity	3.75e-05	0.000255	CcSEcCtD
Pramipexole—Gastrointestinal pain—Orlistat—obesity	3.74e-05	0.000255	CcSEcCtD
Pramipexole—Hyperhidrosis—Bupropion—obesity	3.73e-05	0.000254	CcSEcCtD
Pramipexole—Anorexia—Bupropion—obesity	3.68e-05	0.000251	CcSEcCtD
Pramipexole—Haematuria—Topiramate—obesity	3.67e-05	0.000251	CcSEcCtD
Pramipexole—Feeling abnormal—Sibutramine—obesity	3.65e-05	0.000249	CcSEcCtD
Pramipexole—Epistaxis—Topiramate—obesity	3.63e-05	0.000248	CcSEcCtD
Pramipexole—Urticaria—Orlistat—obesity	3.63e-05	0.000248	CcSEcCtD
Pramipexole—Gastrointestinal pain—Sibutramine—obesity	3.62e-05	0.000247	CcSEcCtD
Pramipexole—Sinusitis—Topiramate—obesity	3.62e-05	0.000246	CcSEcCtD
Pramipexole—Abdominal pain—Orlistat—obesity	3.61e-05	0.000246	CcSEcCtD
Pramipexole—Body temperature increased—Orlistat—obesity	3.61e-05	0.000246	CcSEcCtD
Pramipexole—Hypotension—Bupropion—obesity	3.6e-05	0.000246	CcSEcCtD
Pramipexole—Bradycardia—Topiramate—obesity	3.52e-05	0.00024	CcSEcCtD
Pramipexole—Urticaria—Sibutramine—obesity	3.52e-05	0.00024	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Bupropion—obesity	3.51e-05	0.00024	CcSEcCtD
Pramipexole—Abdominal pain—Sibutramine—obesity	3.5e-05	0.000239	CcSEcCtD
Pramipexole—Body temperature increased—Sibutramine—obesity	3.5e-05	0.000239	CcSEcCtD
Pramipexole—Insomnia—Bupropion—obesity	3.49e-05	0.000238	CcSEcCtD
Pramipexole—Rhinitis—Topiramate—obesity	3.47e-05	0.000236	CcSEcCtD
Pramipexole—Paraesthesia—Bupropion—obesity	3.46e-05	0.000236	CcSEcCtD
Pramipexole—Hypoaesthesia—Topiramate—obesity	3.44e-05	0.000235	CcSEcCtD
Pramipexole—Hallucination—Topiramate—obesity	3.44e-05	0.000235	CcSEcCtD
Pramipexole—Dyspnoea—Bupropion—obesity	3.44e-05	0.000234	CcSEcCtD
Pramipexole—Pharyngitis—Topiramate—obesity	3.43e-05	0.000234	CcSEcCtD
Pramipexole—Somnolence—Bupropion—obesity	3.43e-05	0.000234	CcSEcCtD
Pramipexole—Urinary tract disorder—Topiramate—obesity	3.42e-05	0.000233	CcSEcCtD
Pramipexole—Oedema peripheral—Topiramate—obesity	3.41e-05	0.000232	CcSEcCtD
Pramipexole—Connective tissue disorder—Topiramate—obesity	3.4e-05	0.000232	CcSEcCtD
Pramipexole—Dyspepsia—Bupropion—obesity	3.4e-05	0.000232	CcSEcCtD
Pramipexole—Urethral disorder—Topiramate—obesity	3.39e-05	0.000231	CcSEcCtD
Pramipexole—Hypersensitivity—Orlistat—obesity	3.37e-05	0.00023	CcSEcCtD
Pramipexole—Decreased appetite—Bupropion—obesity	3.35e-05	0.000229	CcSEcCtD
Pramipexole—Visual impairment—Topiramate—obesity	3.33e-05	0.000227	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Bupropion—obesity	3.33e-05	0.000227	CcSEcCtD
Pramipexole—Fatigue—Bupropion—obesity	3.33e-05	0.000227	CcSEcCtD
Pramipexole—Constipation—Bupropion—obesity	3.3e-05	0.000225	CcSEcCtD
Pramipexole—Pain—Bupropion—obesity	3.3e-05	0.000225	CcSEcCtD
Pramipexole—Asthenia—Orlistat—obesity	3.28e-05	0.000224	CcSEcCtD
Pramipexole—Hypersensitivity—Sibutramine—obesity	3.26e-05	0.000222	CcSEcCtD
Pramipexole—Pruritus—Orlistat—obesity	3.23e-05	0.000221	CcSEcCtD
Pramipexole—Eye disorder—Topiramate—obesity	3.23e-05	0.00022	CcSEcCtD
Pramipexole—Tinnitus—Topiramate—obesity	3.23e-05	0.00022	CcSEcCtD
Pramipexole—Cardiac disorder—Topiramate—obesity	3.21e-05	0.000219	CcSEcCtD
Pramipexole—Flushing—Topiramate—obesity	3.21e-05	0.000219	CcSEcCtD
Pramipexole—Feeling abnormal—Bupropion—obesity	3.18e-05	0.000217	CcSEcCtD
Pramipexole—Asthenia—Sibutramine—obesity	3.17e-05	0.000216	CcSEcCtD
Pramipexole—Gastrointestinal pain—Bupropion—obesity	3.15e-05	0.000215	CcSEcCtD
Pramipexole—Angiopathy—Topiramate—obesity	3.14e-05	0.000214	CcSEcCtD
Pramipexole—Pruritus—Sibutramine—obesity	3.13e-05	0.000213	CcSEcCtD
Pramipexole—Diarrhoea—Orlistat—obesity	3.13e-05	0.000213	CcSEcCtD
Pramipexole—Immune system disorder—Topiramate—obesity	3.12e-05	0.000213	CcSEcCtD
Pramipexole—Mediastinal disorder—Topiramate—obesity	3.12e-05	0.000213	CcSEcCtD
Pramipexole—Chills—Topiramate—obesity	3.1e-05	0.000212	CcSEcCtD
Pramipexole—Urticaria—Bupropion—obesity	3.06e-05	0.000209	CcSEcCtD
Pramipexole—Alopecia—Topiramate—obesity	3.06e-05	0.000208	CcSEcCtD
Pramipexole—Abdominal pain—Bupropion—obesity	3.05e-05	0.000208	CcSEcCtD
Pramipexole—Body temperature increased—Bupropion—obesity	3.05e-05	0.000208	CcSEcCtD
Pramipexole—Mental disorder—Topiramate—obesity	3.03e-05	0.000207	CcSEcCtD
Pramipexole—Diarrhoea—Sibutramine—obesity	3.03e-05	0.000206	CcSEcCtD
Pramipexole—Dizziness—Orlistat—obesity	3.02e-05	0.000206	CcSEcCtD
Pramipexole—Malnutrition—Topiramate—obesity	3.01e-05	0.000205	CcSEcCtD
Pramipexole—Erythema—Topiramate—obesity	3.01e-05	0.000205	CcSEcCtD
Pramipexole—Flatulence—Topiramate—obesity	2.97e-05	0.000202	CcSEcCtD
Pramipexole—Tension—Topiramate—obesity	2.96e-05	0.000201	CcSEcCtD
Pramipexole—Dysgeusia—Topiramate—obesity	2.95e-05	0.000201	CcSEcCtD
Pramipexole—Dizziness—Sibutramine—obesity	2.93e-05	0.0002	CcSEcCtD
Pramipexole—Nervousness—Topiramate—obesity	2.92e-05	0.000199	CcSEcCtD
Pramipexole—Back pain—Topiramate—obesity	2.91e-05	0.000199	CcSEcCtD
Pramipexole—Vomiting—Orlistat—obesity	2.91e-05	0.000198	CcSEcCtD
Pramipexole—Muscle spasms—Topiramate—obesity	2.9e-05	0.000197	CcSEcCtD
Pramipexole—Rash—Orlistat—obesity	2.88e-05	0.000197	CcSEcCtD
Pramipexole—Dermatitis—Orlistat—obesity	2.88e-05	0.000196	CcSEcCtD
Pramipexole—Headache—Orlistat—obesity	2.86e-05	0.000195	CcSEcCtD
Pramipexole—Hypersensitivity—Bupropion—obesity	2.84e-05	0.000194	CcSEcCtD
Pramipexole—Vision blurred—Topiramate—obesity	2.84e-05	0.000194	CcSEcCtD
Pramipexole—Tremor—Topiramate—obesity	2.82e-05	0.000192	CcSEcCtD
Pramipexole—Vomiting—Sibutramine—obesity	2.81e-05	0.000192	CcSEcCtD
Pramipexole—Ill-defined disorder—Topiramate—obesity	2.79e-05	0.000191	CcSEcCtD
Pramipexole—Rash—Sibutramine—obesity	2.79e-05	0.00019	CcSEcCtD
Pramipexole—Dermatitis—Sibutramine—obesity	2.79e-05	0.00019	CcSEcCtD
Pramipexole—Anaemia—Topiramate—obesity	2.78e-05	0.00019	CcSEcCtD
Pramipexole—Headache—Sibutramine—obesity	2.77e-05	0.000189	CcSEcCtD
Pramipexole—Asthenia—Bupropion—obesity	2.77e-05	0.000189	CcSEcCtD
Pramipexole—Agitation—Topiramate—obesity	2.77e-05	0.000189	CcSEcCtD
Pramipexole—Pruritus—Bupropion—obesity	2.73e-05	0.000186	CcSEcCtD
Pramipexole—Nausea—Orlistat—obesity	2.72e-05	0.000185	CcSEcCtD
Pramipexole—Malaise—Topiramate—obesity	2.72e-05	0.000185	CcSEcCtD
Pramipexole—Vertigo—Topiramate—obesity	2.71e-05	0.000184	CcSEcCtD
Pramipexole—Syncope—Topiramate—obesity	2.7e-05	0.000184	CcSEcCtD
Pramipexole—Leukopenia—Topiramate—obesity	2.7e-05	0.000184	CcSEcCtD
Pramipexole—Palpitations—Topiramate—obesity	2.66e-05	0.000181	CcSEcCtD
Pramipexole—Loss of consciousness—Topiramate—obesity	2.65e-05	0.00018	CcSEcCtD
Pramipexole—Diarrhoea—Bupropion—obesity	2.64e-05	0.00018	CcSEcCtD
Pramipexole—Nausea—Sibutramine—obesity	2.63e-05	0.000179	CcSEcCtD
Pramipexole—Cough—Topiramate—obesity	2.63e-05	0.000179	CcSEcCtD
Pramipexole—Convulsion—Topiramate—obesity	2.61e-05	0.000178	CcSEcCtD
Pramipexole—Hypertension—Topiramate—obesity	2.6e-05	0.000177	CcSEcCtD
Pramipexole—Myalgia—Topiramate—obesity	2.56e-05	0.000175	CcSEcCtD
Pramipexole—Chest pain—Topiramate—obesity	2.56e-05	0.000175	CcSEcCtD
Pramipexole—Arthralgia—Topiramate—obesity	2.56e-05	0.000175	CcSEcCtD
Pramipexole—Anxiety—Topiramate—obesity	2.55e-05	0.000174	CcSEcCtD
Pramipexole—Dizziness—Bupropion—obesity	2.55e-05	0.000174	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	2.55e-05	0.000174	CcSEcCtD
Pramipexole—Discomfort—Topiramate—obesity	2.53e-05	0.000173	CcSEcCtD
Pramipexole—Dry mouth—Topiramate—obesity	2.51e-05	0.000171	CcSEcCtD
Pramipexole—Confusional state—Topiramate—obesity	2.48e-05	0.000169	CcSEcCtD
Pramipexole—Oedema—Topiramate—obesity	2.46e-05	0.000168	CcSEcCtD
Pramipexole—Vomiting—Bupropion—obesity	2.45e-05	0.000167	CcSEcCtD
Pramipexole—Infection—Topiramate—obesity	2.44e-05	0.000166	CcSEcCtD
Pramipexole—Rash—Bupropion—obesity	2.43e-05	0.000166	CcSEcCtD
Pramipexole—Dermatitis—Bupropion—obesity	2.43e-05	0.000166	CcSEcCtD
Pramipexole—Shock—Topiramate—obesity	2.42e-05	0.000165	CcSEcCtD
Pramipexole—Headache—Bupropion—obesity	2.42e-05	0.000165	CcSEcCtD
Pramipexole—Nervous system disorder—Topiramate—obesity	2.41e-05	0.000164	CcSEcCtD
Pramipexole—Thrombocytopenia—Topiramate—obesity	2.41e-05	0.000164	CcSEcCtD
Pramipexole—Tachycardia—Topiramate—obesity	2.4e-05	0.000164	CcSEcCtD
Pramipexole—Skin disorder—Topiramate—obesity	2.39e-05	0.000163	CcSEcCtD
Pramipexole—Hyperhidrosis—Topiramate—obesity	2.38e-05	0.000162	CcSEcCtD
Pramipexole—Anorexia—Topiramate—obesity	2.34e-05	0.00016	CcSEcCtD
Pramipexole—Hypotension—Topiramate—obesity	2.3e-05	0.000157	CcSEcCtD
Pramipexole—Nausea—Bupropion—obesity	2.29e-05	0.000156	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Topiramate—obesity	2.24e-05	0.000153	CcSEcCtD
Pramipexole—Insomnia—Topiramate—obesity	2.22e-05	0.000152	CcSEcCtD
Pramipexole—Paraesthesia—Topiramate—obesity	2.21e-05	0.00015	CcSEcCtD
Pramipexole—Dyspnoea—Topiramate—obesity	2.19e-05	0.000149	CcSEcCtD
Pramipexole—Somnolence—Topiramate—obesity	2.18e-05	0.000149	CcSEcCtD
Pramipexole—Dyspepsia—Topiramate—obesity	2.16e-05	0.000148	CcSEcCtD
Pramipexole—Decreased appetite—Topiramate—obesity	2.14e-05	0.000146	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Topiramate—obesity	2.12e-05	0.000145	CcSEcCtD
Pramipexole—Fatigue—Topiramate—obesity	2.12e-05	0.000144	CcSEcCtD
Pramipexole—Pain—Topiramate—obesity	2.1e-05	0.000143	CcSEcCtD
Pramipexole—Constipation—Topiramate—obesity	2.1e-05	0.000143	CcSEcCtD
Pramipexole—Feeling abnormal—Topiramate—obesity	2.03e-05	0.000138	CcSEcCtD
Pramipexole—Gastrointestinal pain—Topiramate—obesity	2.01e-05	0.000137	CcSEcCtD
Pramipexole—Urticaria—Topiramate—obesity	1.95e-05	0.000133	CcSEcCtD
Pramipexole—Abdominal pain—Topiramate—obesity	1.94e-05	0.000132	CcSEcCtD
Pramipexole—Body temperature increased—Topiramate—obesity	1.94e-05	0.000132	CcSEcCtD
Pramipexole—Hypersensitivity—Topiramate—obesity	1.81e-05	0.000123	CcSEcCtD
Pramipexole—Asthenia—Topiramate—obesity	1.76e-05	0.00012	CcSEcCtD
Pramipexole—Pruritus—Topiramate—obesity	1.74e-05	0.000119	CcSEcCtD
Pramipexole—Diarrhoea—Topiramate—obesity	1.68e-05	0.000115	CcSEcCtD
Pramipexole—Dizziness—Topiramate—obesity	1.63e-05	0.000111	CcSEcCtD
Pramipexole—Vomiting—Topiramate—obesity	1.56e-05	0.000107	CcSEcCtD
Pramipexole—Rash—Topiramate—obesity	1.55e-05	0.000106	CcSEcCtD
Pramipexole—Dermatitis—Topiramate—obesity	1.55e-05	0.000106	CcSEcCtD
Pramipexole—Headache—Topiramate—obesity	1.54e-05	0.000105	CcSEcCtD
Pramipexole—Nausea—Topiramate—obesity	1.46e-05	9.95e-05	CcSEcCtD
Pramipexole—DRD2—Signaling Pathways—PIK3CG—obesity	1.27e-06	1.24e-05	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—AKT1—obesity	1.27e-06	1.24e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TYK2—obesity	1.27e-06	1.23e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—PIK3CD—obesity	1.27e-06	1.23e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MMP9—obesity	1.27e-06	1.23e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—LEP—obesity	1.26e-06	1.23e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—APOE—obesity	1.26e-06	1.23e-05	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—PIK3CA—obesity	1.26e-06	1.23e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SERPINE1—obesity	1.26e-06	1.23e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—RHOA—obesity	1.26e-06	1.22e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MAPK8—obesity	1.26e-06	1.22e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IRS1—obesity	1.26e-06	1.22e-05	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—PIK3CA—obesity	1.25e-06	1.22e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—AKT1—obesity	1.25e-06	1.22e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SERPINE1—obesity	1.25e-06	1.22e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PIK3CG—obesity	1.25e-06	1.22e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL6—obesity	1.25e-06	1.22e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CAV1—obesity	1.25e-06	1.22e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—APOA1—obesity	1.25e-06	1.21e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MMP9—obesity	1.25e-06	1.21e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—PIK3R1—obesity	1.25e-06	1.21e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NOS3—obesity	1.25e-06	1.21e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IRS1—obesity	1.24e-06	1.2e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PIK3CD—obesity	1.23e-06	1.2e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MAPK8—obesity	1.23e-06	1.2e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PIK3CB—obesity	1.23e-06	1.2e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—AKT1—obesity	1.23e-06	1.2e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TYK2—obesity	1.22e-06	1.19e-05	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—PIK3CA—obesity	1.22e-06	1.19e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PTGS2—obesity	1.22e-06	1.19e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TYK2—obesity	1.22e-06	1.19e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SERPINE1—obesity	1.22e-06	1.19e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—RHOA—obesity	1.21e-06	1.18e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MAPK8—obesity	1.21e-06	1.18e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—POMC—obesity	1.21e-06	1.18e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—RHOA—obesity	1.21e-06	1.18e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—AKT1—obesity	1.21e-06	1.18e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ESR1—obesity	1.2e-06	1.17e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—INS—obesity	1.2e-06	1.17e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NOS3—obesity	1.2e-06	1.17e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—PIK3R1—obesity	1.2e-06	1.17e-05	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—AKT1—obesity	1.2e-06	1.17e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PIK3CD—obesity	1.2e-06	1.16e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—PIK3R1—obesity	1.2e-06	1.16e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NOS3—obesity	1.2e-06	1.16e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—POMC—obesity	1.19e-06	1.16e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MMP9—obesity	1.19e-06	1.16e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—F2—obesity	1.19e-06	1.16e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PRKCB—obesity	1.19e-06	1.16e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—PIK3CA—obesity	1.19e-06	1.15e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TYK2—obesity	1.19e-06	1.15e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—INS—obesity	1.18e-06	1.15e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCL2—obesity	1.18e-06	1.15e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—PIK3CA—obesity	1.18e-06	1.15e-05	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—AKT1—obesity	1.18e-06	1.15e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ALB—obesity	1.18e-06	1.15e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL6—obesity	1.18e-06	1.15e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—RHOA—obesity	1.18e-06	1.14e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—BAD—obesity	1.18e-06	1.14e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCL2—obesity	1.17e-06	1.13e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IGF1—obesity	1.16e-06	1.13e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL6—obesity	1.16e-06	1.13e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AKT2—obesity	1.16e-06	1.13e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PIK3R1—obesity	1.16e-06	1.13e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NOS3—obesity	1.16e-06	1.13e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MAPK8—obesity	1.16e-06	1.13e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—AKT1—obesity	1.15e-06	1.12e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—STAT3—obesity	1.15e-06	1.12e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—PIK3CB—obesity	1.15e-06	1.12e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MTOR—obesity	1.15e-06	1.12e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IGF1—obesity	1.15e-06	1.11e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—PIK3CA—obesity	1.15e-06	1.11e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AKT2—obesity	1.14e-06	1.11e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—PIK3CA—obesity	1.14e-06	1.11e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PIK3CG—obesity	1.14e-06	1.11e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PIK3R1—obesity	1.13e-06	1.1e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—NOS3—obesity	1.13e-06	1.1e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—STAT3—obesity	1.13e-06	1.1e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IRS1—obesity	1.13e-06	1.1e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MMP9—obesity	1.12e-06	1.09e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PIK3CD—obesity	1.12e-06	1.09e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MTOR—obesity	1.11e-06	1.08e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—PIK3CB—obesity	1.11e-06	1.08e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—PIK3CA—obesity	1.11e-06	1.08e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—STAT3—obesity	1.11e-06	1.08e-05	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—PIK3CA—obesity	1.11e-06	1.08e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MMP9—obesity	1.11e-06	1.08e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SERPINE1—obesity	1.11e-06	1.08e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—PIK3CB—obesity	1.1e-06	1.07e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MTOR—obesity	1.1e-06	1.07e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PIK3CD—obesity	1.1e-06	1.07e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MAPK8—obesity	1.09e-06	1.06e-05	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—PIK3CA—obesity	1.09e-06	1.06e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—AKT1—obesity	1.09e-06	1.06e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SERPINE1—obesity	1.09e-06	1.06e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—POMC—obesity	1.08e-06	1.05e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—INS—obesity	1.08e-06	1.05e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MAPK8—obesity	1.08e-06	1.05e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TYK2—obesity	1.08e-06	1.05e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MTOR—obesity	1.07e-06	1.05e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PIK3CB—obesity	1.07e-06	1.05e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—AKT1—obesity	1.07e-06	1.04e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MYC—obesity	1.07e-06	1.04e-05	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—AKT1—obesity	1.07e-06	1.04e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RHOA—obesity	1.07e-06	1.04e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TGFB1—obesity	1.07e-06	1.04e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCL2—obesity	1.06e-06	1.03e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TYK2—obesity	1.06e-06	1.03e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—STAT3—obesity	1.06e-06	1.03e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PIK3R1—obesity	1.06e-06	1.03e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NOS3—obesity	1.06e-06	1.03e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL6—obesity	1.05e-06	1.02e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RHOA—obesity	1.05e-06	1.02e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL6—obesity	1.05e-06	1.02e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MYC—obesity	1.05e-06	1.02e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TGFB1—obesity	1.04e-06	1.02e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PIK3CB—obesity	1.04e-06	1.02e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IGF1—obesity	1.04e-06	1.01e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AKT2—obesity	1.04e-06	1.01e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NOS3—obesity	1.04e-06	1.01e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PIK3R1—obesity	1.04e-06	1.01e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PTGS2—obesity	1.03e-06	1.01e-05	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—AKT1—obesity	1.03e-06	1e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MYC—obesity	1.03e-06	1e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TGFB1—obesity	1.03e-06	1e-05	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—AKT1—obesity	1.02e-06	9.98e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL6—obesity	1.01e-06	9.87e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL6—obesity	1.01e-06	9.82e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—PIK3CA—obesity	1.01e-06	9.79e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PIK3CD—obesity	1e-06	9.74e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MMP9—obesity	9.99e-07	9.73e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—STAT3—obesity	9.97e-07	9.71e-06	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—AKT1—obesity	9.97e-07	9.7e-06	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	9.91e-07	9.65e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SERPINE1—obesity	9.9e-07	9.63e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—PIK3CA—obesity	9.89e-07	9.63e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—STAT3—obesity	9.84e-07	9.58e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MYC—obesity	9.83e-07	9.56e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL6—obesity	9.81e-07	9.55e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TGFB1—obesity	9.8e-07	9.54e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MTOR—obesity	9.74e-07	9.48e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PIK3CB—obesity	9.74e-07	9.48e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MAPK8—obesity	9.72e-07	9.46e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—AKT1—obesity	9.69e-07	9.43e-06	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—AKT1—obesity	9.67e-07	9.41e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MMP9—obesity	9.65e-07	9.39e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TYK2—obesity	9.63e-07	9.37e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MMP9—obesity	9.6e-07	9.34e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PIK3CB—obesity	9.59e-07	9.33e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MTOR—obesity	9.59e-07	9.33e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RHOA—obesity	9.55e-07	9.29e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PIK3R1—obesity	9.45e-07	9.2e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NOS3—obesity	9.45e-07	9.2e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MAPK8—obesity	9.38e-07	9.13e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—AKT1—obesity	9.35e-07	9.11e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MMP9—obesity	9.33e-07	9.08e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MAPK8—obesity	9.33e-07	9.08e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—AKT1—obesity	9.31e-07	9.06e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MYC—obesity	9.27e-07	9.02e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TGFB1—obesity	9.24e-07	9e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MYC—obesity	9.14e-07	8.9e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TGFB1—obesity	9.12e-07	8.88e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MAPK8—obesity	9.08e-07	8.83e-06	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—PIK3CA—obesity	9.07e-07	8.83e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—AKT1—obesity	9.05e-07	8.81e-06	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—AKT1—obesity	9.04e-07	8.8e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—PIK3CA—obesity	9e-07	8.76e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL6—obesity	8.9e-07	8.67e-06	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—AKT1—obesity	8.9e-07	8.66e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—STAT3—obesity	8.88e-07	8.65e-06	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—PIK3CA—obesity	8.88e-07	8.64e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL6—obesity	8.76e-07	8.53e-06	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—PIK3CA—obesity	8.74e-07	8.51e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MTOR—obesity	8.72e-07	8.49e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PIK3CB—obesity	8.72e-07	8.49e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—STAT3—obesity	8.58e-07	8.35e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—STAT3—obesity	8.53e-07	8.3e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MMP9—obesity	8.47e-07	8.24e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—PIK3CA—obesity	8.34e-07	8.12e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MMP9—obesity	8.33e-07	8.11e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—STAT3—obesity	8.3e-07	8.08e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MYC—obesity	8.25e-07	8.03e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MAPK8—obesity	8.24e-07	8.02e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TGFB1—obesity	8.23e-07	8.02e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—AKT1—obesity	8.21e-07	7.99e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MAPK8—obesity	8.1e-07	7.89e-06	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—AKT1—obesity	8.1e-07	7.88e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—AKT1—obesity	8.08e-07	7.87e-06	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PIK3CA—obesity	8.05e-07	7.83e-06	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL6—obesity	8.03e-07	7.82e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL6—obesity	7.97e-07	7.76e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MYC—obesity	7.97e-07	7.76e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TGFB1—obesity	7.95e-07	7.74e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MYC—obesity	7.93e-07	7.72e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TGFB1—obesity	7.91e-07	7.7e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—PIK3CA—obesity	7.87e-07	7.66e-06	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL6—obesity	7.86e-07	7.65e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PIK3CA—obesity	7.83e-07	7.62e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—PIK3CA—obesity	7.76e-07	7.55e-06	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL6—obesity	7.74e-07	7.53e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MYC—obesity	7.71e-07	7.51e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TGFB1—obesity	7.69e-07	7.49e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MMP9—obesity	7.58e-07	7.38e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—STAT3—obesity	7.53e-07	7.33e-06	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PIK3CA—obesity	7.5e-07	7.3e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—STAT3—obesity	7.41e-07	7.21e-06	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—AKT1—obesity	7.41e-07	7.21e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL6—obesity	7.39e-07	7.19e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MAPK8—obesity	7.37e-07	7.18e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—AKT1—obesity	7.35e-07	7.16e-06	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—AKT1—obesity	7.25e-07	7.06e-06	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—AKT1—obesity	7.14e-07	6.95e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—PIK3CA—obesity	7.01e-07	6.82e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MYC—obesity	7e-07	6.81e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TGFB1—obesity	6.98e-07	6.79e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL6—obesity	6.97e-07	6.78e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MYC—obesity	6.88e-07	6.7e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL6—obesity	6.87e-07	6.69e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TGFB1—obesity	6.87e-07	6.68e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AKT1—obesity	6.81e-07	6.63e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—PIK3CA—obesity	6.76e-07	6.58e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—STAT3—obesity	6.74e-07	6.56e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—PIK3CA—obesity	6.73e-07	6.55e-06	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—AKT1—obesity	6.57e-07	6.4e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PIK3CA—obesity	6.55e-07	6.37e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AKT1—obesity	6.43e-07	6.26e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—AKT1—obesity	6.39e-07	6.22e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PIK3CA—obesity	6.36e-07	6.19e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AKT1—obesity	6.34e-07	6.17e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MYC—obesity	6.26e-07	6.1e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TGFB1—obesity	6.25e-07	6.08e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6—obesity	6.21e-07	6.04e-06	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—AKT1—obesity	6.13e-07	5.96e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6—obesity	5.99e-07	5.83e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6—obesity	5.96e-07	5.8e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PIK3CA—obesity	5.94e-07	5.78e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PIK3CA—obesity	5.84e-07	5.69e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6—obesity	5.8e-07	5.64e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AKT1—obesity	5.72e-07	5.57e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AKT1—obesity	5.53e-07	5.38e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AKT1—obesity	5.5e-07	5.35e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AKT1—obesity	5.35e-07	5.2e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PIK3CA—obesity	5.32e-07	5.18e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6—obesity	5.26e-07	5.12e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—AKT1—obesity	5.19e-07	5.06e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6—obesity	5.17e-07	5.04e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AKT1—obesity	4.85e-07	4.72e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AKT1—obesity	4.77e-07	4.65e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6—obesity	4.71e-07	4.58e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AKT1—obesity	4.34e-07	4.23e-06	CbGpPWpGaD
